Fexinidazole Tablet
NDC Package 0024-4512-24
Package Information
Fexinidazole tablets are indicated for the treatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in patients 6 years of age and older and weighing at least 20 kg. This formulation utilizes a tablet delivery system. Marketed by Sanofi-aventis U.s. Llc, this product is identified by NDC 0024-4512 and is authorized under FDA application NDA214429.
Identification & Billing
- RxCUI: 2564151 - fexinidazole 600 MG Oral Tablet
- RxCUI: 2564152 - {24 (fexinidazole 600 MG Oral Tablet) } Pack
- RxCUI: 2564152 - fexinidazole 600 MG Tablet 10-Day Dose Pack (35 KG+)
- RxCUI: 2564153 - {14 (fexinidazole 600 MG Oral Tablet) } Pack
- RxCUI: 2564153 - fexinidazole 600 MG Tablet 10-Day Dose Pack (20 KG - < 35 KG)
Clinical Specifications
- Cytochrome P450 1A2 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 1A2 Inhibitors - [MoA] (Mechanism of Action)
- Cytochrome P450 2B6 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 2B6 Inhibitors - [MoA] (Mechanism of Action)
- Cytochrome P450 2C19 Inhibitors - [MoA] (Mechanism of Action)
- Cytochrome P450 2D6 Inhibitors - [MoA] (Mechanism of Action)
- Cytochrome P450 3A4 Inhibitors - [MoA] (Mechanism of Action)
- Cytochrome P450 3A5 Inhibitors - [MoA] (Mechanism of Action)
- Multidrug and Toxin Extrusion Transporter 1 Inhibitors - [MoA] (Mechanism of Action)
- Multidrug and Toxin Extrusion Transporter 2 K Inhibitors - [MoA] (Mechanism of Action)
- Nitroimidazole Antimicrobial - [EPC] (Established Pharmacologic Class)
- Nitroimidazoles - [CS]
- Organic Anion Transporter 1 Inhibitors - [MoA] (Mechanism of Action)
- Organic Anion Transporter 3 Inhibitors - [MoA] (Mechanism of Action)
- Organic Anion Transporting Polypeptide 1B1 Inhibitors - [MoA] (Mechanism of Action)
- Organic Anion Transporting Polypeptide 1B3 Inhibitors - [MoA] (Mechanism of Action)
- Organic Cation Transporter 2 Inhibitors - [MoA] (Mechanism of Action)
Regulatory & Marketing
Hierarchy Structure
- 0024 - Sanofi-aventis U.s. Llc
- 0024-4512 - Fexinidazole
- 0024-4512-24 - 24 TABLET in 1 DOSE PACK
- 0024-4512 - Fexinidazole
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0024-4512). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0024-4512-24 identifies a specific commercial package of 24 tablet in 1 dose pack of Fexinidazole, a human prescription drug labeled by Sanofi-aventis U.s. Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 24 billable units per package. This tablet is formulated for oral use and contains fexinidazole as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sanofi-aventis U.s. Llc on July 16, 2021. The current certification is valid through December 31, 2026.
How is this Sanofi-aventis U.s. Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00024451224. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 24 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.